CMV Management in Solid Organ Transplantation
Insights and Challenges from the New 4th Consensus Guidelines
- Watch CMV Stream 2025 for an in-depth discussion on challenging issues and open questions from the recently published 4th International Consensus Guidelines on the management of CMV in SOT
Scientific Program
Best prevention methods including novel agents
Monitoring after prophylaxis or treatment
Moving towards personalized management
Interpretation of low viral loads
Resistant CMV infection
Use of Immunoglobulins
Discussion of combination therapies
Join hundreds of transplant professionals who have already watched the live broadcast of CMV Stream 2025.
We hope you'll find this insightful discussion beneficial for your practice.
Speaker Panel
Camille N. Kotton MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases. Massachusetts General Hospital
Associate Professor, Harvard Medical School
Atul Humar, MD, MSc
Professor, University of Toronto
Transplant Infectious Diseases
Ajmera Transplant Center
Lara Danziger-Isakov, MD, MPH
Professor of Pediatrics
Interim Director, Infectious Disease
Director, Immunocompromised Host Infectious Diseases
Cincinnati Children’s Hospital Medical Center
Marcus Pereira MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
Erika D. Lease, MD, FCCP
Professor, Division of Pulmonary, Critical Care, and Sleep Medicine
Medical Director, Lung Transplant Program
Attending, Solid Organ Transplant Infectious Diseases Program
University of Washington
